Member of the Association of American Physicians
His main research concerns Internal medicine, Cancer, Oncology, Breast cancer and Leukemia. His biological study spans a wide range of topics, including Gastroenterology and Immunology. His work deals with themes such as Odds ratio, Pathology, Cancer research and Chronic lymphocytic leukemia, which intersect with Cancer.
His Pathology research includes themes of Nevus and Dysplastic nevus. His Oncology study integrates concerns from other disciplines, such as Colorectal cancer, Randomized controlled trial and Risk factor. He interconnects Gene mutation and Single-nucleotide polymorphism, Genotype in the investigation of issues within Breast cancer.
His primary scientific interests are in Internal medicine, Cancer, Oncology, Breast cancer and Genetics. Internal medicine is closely attributed to Gynecology in his study. In his research on the topic of Cancer, Nevus, Dermatology and Hereditary Melanoma is strongly related with Pathology.
His Oncology study combines topics from a wide range of disciplines, such as BRCA mutation, Relative risk, Colorectal cancer, Leukemia and Prostate cancer. His Breast cancer study combines topics in areas such as Cancer research and Single-nucleotide polymorphism, Genotype. His research in Ovarian cancer intersects with topics in Gynecologic oncology and Germline mutation.
The scientist’s investigation covers issues in Internal medicine, Cancer, Oncology, Breast cancer and Ovarian cancer. The concepts of his Cancer study are interwoven with issues in African origin, Gastroenterology, Medical genetics, Benign tumor and Exome. His Oncology research is multidisciplinary, incorporating elements of Absolute risk reduction, Germline, Heritability, Telomere and Prostate cancer.
His Breast cancer research incorporates themes from Genome-wide association study, Cohort study, Mutation, Prospective cohort study and Risk factor. His study in Ovarian cancer is interdisciplinary in nature, drawing from both Lung cancer, Gerontology and Obstetrics. His studies deal with areas such as Logistic regression and Genotype as well as Odds ratio.
His primary areas of investigation include Internal medicine, Oncology, Cancer, Breast cancer and Genome-wide association study. His research links Gastroenterology with Internal medicine. The Oncology study combines topics in areas such as Absolute risk reduction, Cohort and Medical genetics.
His research integrates issues of Odds ratio, Serous fluid, Peritoneal Neoplasm and Myotonic dystrophy in his study of Cancer. His work carried out in the field of Breast cancer brings together such families of science as Prostate cancer, Genetic predisposition and Risk factor. Mark H. Greene studied Genome-wide association study and Genetic association that intersect with Quantitative trait locus, Locus and Heritability.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
Wallace H. Clark;David E. Elder;Dupont Guerry;Martin N. Epstein.
Human Pathology (1984)
Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'.
Wallace H. Clark;Ronald R. Reimer;Mark Greene;Ann M. Ainsworth.
Archives of Dermatology (1978)
Dysplastic nevus syndrome: A phenotypic association of sporadic cutaneous melanoma
David E. Elder;Leonard I. Goldman;Susan C. Goldman;Mark H. Greene.
Cancer (1980)
High Risk of Malignant Melanoma in Melanoma-Prone Families with Dysplastic Nevi
Mark H. Greene;Wallace H. Clark;Margaret A. Tucker;Kenneth H. Kraemer.
Annals of Internal Medicine (1985)
Cancer incidence in persons with Fanconi anemia.
Philip S. Rosenberg;Mark H. Greene;Blanche P. Alter.
Blood (2003)
Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
Kelly L. Bolton;Kelly L. Bolton;Georgia Chenevix-Trench;Cindy Goh;Siegal Sadetzki.
JAMA (2012)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek.
Cancer Epidemiology, Biomarkers & Prevention (2012)
Detectable clonal mosaicism and its relationship to aging and cancer
Kevin B. Jacobs;Kevin B. Jacobs;Meredith Yeager;Meredith Yeager;Weiyin Zhou;Weiyin Zhou;Sholom Wacholder.
Nature Genetics (2012)
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p
Sherri J. Bale;Nicholas C. Dracopoli;Margaret A. Tucker;Wallace H. Clark.
The New England Journal of Medicine (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Toronto
University of Pennsylvania
Institute Curie
University of Cambridge
QIMR Berghofer Medical Research Institute
University of Cambridge
Sheba Medical Center
Cancer Council Victoria
Mayo Clinic
City Of Hope National Medical Center
Shandong University of Science and Technology
State University of Campinas
Tsinghua University
University of Oxford
The Ohio State University
New York University
Claude Bernard University Lyon 1
Spanish National Research Council
University of Guelph
University of British Columbia
University of Eastern Finland
National Institutes of Health
Columbia University Medical Center
Norwegian School of Economics
American University
Stanford University